Pilot trial sought to determine the efficacy of using GO-EXCAP, a mobile application, to improve exercise frequency and duration in older patients receiving chemotherapy for myeloid neoplasms.
Gender balance in cancer surveys was found to have relatively little effect on survey outcomes, according to results of a study presented at the 2022 ASCO Annual Meeting. Surveying patients with myeloproliferative neoplasms (MPN) has given valuable insight into polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) subtypes. However, independent surveys have included a…
